TA-65 Supplements
About TA-65 Supplements
Quick answer: TA-65 is a single, highly purified compound from the root of Astragalus membranaceus that activates telomerase, the enzyme that maintains telomeres. In a 12-month double-blind trial, people taking 250 Units a day significantly increased telomere length by 530 base pairs, while the placebo group lost 290 base pairs. RevGenetics offers authentic TA-65 in two strengths, 25 mg (250 Units) and 10 mg (100 Units), with public certificates of analysis.*
What are telomeres and telomerase?
Telomeres are protective caps of repeating DNA at the ends of each chromosome. They shorten a little each time a cell divides and, on average, get shorter with age. When telomeres become critically short, cells stop dividing and become senescent. Telomerase is the enzyme that adds DNA back to telomeres. Most adult cells make very little of it.*
What is TA-65?
TA-65 is a single chemical entity purified from Astragalus membranaceus root to more than 98% purity, and it is the most studied telomerase activator sold as a supplement. Generic astragalus products contain whole root or crude extract with little or none of this compound, and they have no human telomere studies behind them. In lab research led by RevGenetics Chief Science Officer Dr. Hector Valenzuela at UCLA, TA-65 increased telomerase activity in human T cells by 1.3 to 3.3 times (Molgora et al., 2013). In aging mice, TA-65 improved several markers of healthspan, including glucose tolerance, bone and skin, without increasing overall cancer incidence; it did not change lifespan (Bernardes de Jesus et al., 2011).*
What human research shows
| Study | Design | What it found |
|---|---|---|
| Salvador et al., Rejuvenation Res 2016 | Double-blind, placebo-controlled, 117 CMV-positive adults aged 53 to 87, 12 months, 250 or 1,000 Units a day | The 250 Unit group significantly increased median telomere length by 530 bp (p=0.005), while the placebo group lost 290 bp, with a significant result already at month 9. Short (20th percentile) telomeres changed similarly. The 1,000 Unit group showed a trend that did not reach statistical significance. |
| Singaravelu et al., OBM Geriatrics 2021 | Double-blind, placebo-controlled, 500 healthy adults aged 45 to 75, 9 months, 100 to 500 Units a day | Senescent CD8+CD28- T cells fell by about 28 cells per microliter in the 100 and 250 Unit groups, versus a small, non-significant rise with placebo. Cell counts were done at UCLA. |
| Harley et al., Rejuvenation Res 2011 | Observational program, 114 adults, 12 months, no placebo group | Senescent T cells fell 7.5% and the share of short telomeres fell, while mean telomere length did not change. |
Bottom line: TA-65 has double-blind human trials on telomere length and immune aging markers, with the clearest telomere result at 250 Units a day. Most studies were funded by TA Sciences, the company that developed TA-65.
Is TA-65 safe?
TA-65 has been designated GRAS (Generally Recognized as Safe) for use in a medical food. No product-related toxicity was reported in three randomized, placebo-controlled studies lasting one year. Talk to your doctor before use if you are pregnant or nursing, take medication, or have a medical condition, and especially if you have cancer or a history of cancer, because telomerase is involved in cell division.
TA-65 25 mg vs 10 mg
| Product | Strength | Supply | Research match |
|---|---|---|---|
| TA-65 25 mg | 25 mg (250 Units) per capsule, 1 a day | 90 capsules, a 90-day protocol | The 250 Unit dose from the 2016 telomere trial and the 2021 immune trial |
| TA-65 10 mg | 10 mg (100 Units) per capsule | See product page | The 100 Unit dose from the 2021 immune trial; not tested in the 2016 telomere trial |
Both products are prepared and shipped on the 1st and the 15th of each month. Certificates of analysis are posted on our certificates page.
Why buy TA-65 from RevGenetics
RevGenetics has sold longevity supplements since 2007 and has been an authorized TA-65 distributor since 2010. Every product comes with a public certificate of analysis, and our science content is reviewed by Dr. Hector Valenzuela, Ph.D., who has published peer-reviewed research on TA-65 in human T cells. Many customers pair TA-65 with NMN, spermidine or resveratrol.
TA-65 FAQ
What is TA-65?
TA-65 is a single, highly purified compound from Astragalus membranaceus root that activates telomerase, the enzyme that maintains telomeres.
What did the TA-65 telomere study find?
In a 12-month double-blind trial of 117 adults aged 53 to 87, the 250 Unit group significantly increased median telomere length by 530 base pairs, while the placebo group lost 290 base pairs.
Should I take 25 mg or 10 mg?
TA-65 25 mg (250 Units) matches the dose used in both the 2016 telomere trial and the 2021 immune trial. TA-65 10 mg (100 Units) matches a dose from the 2021 immune trial and costs less per month.
How is TA-65 different from astragalus?
Generic astragalus contains whole root or crude extract. TA-65 is a single compound purified to more than 98%, and it is the only one of the two with double-blind human telomere studies.
How long does TA-65 take to work?
In the 2016 trial, the telomere difference was significant at 9 and 12 months but not at 6 months. Individual results vary.
Is TA-65 safe for long-term use?
No product-related toxicity was reported in three year-long randomized studies, and TA-65 is designated GRAS for use in a medical food. People with cancer or a history of cancer should talk to their doctor first.
References
- Salvador L, Singaravelu G, Harley CB, Flom P, Suram A, Raffaele JM. A natural product telomerase activator lengthens telomeres in humans: a randomized, double blind, and placebo controlled study. Rejuvenation Res. 2016;19(6):478-484. doi:10.1089/rej.2015.1793
- Singaravelu G, Harley CB, Raffaele JM, Sudhakaran P, Suram A. OBM Geriatrics. 2021;5(2). doi:10.21926/obm.geriatr.2102168
- Harley CB, Liu W, Blasco M, Vera E, Andrews WH, Briggs LA, Raffaele JM. Rejuvenation Res. 2011;14(1):45-56. doi:10.1089/rej.2010.1085
- Bernardes de Jesus B, Schneeberger K, Vera E, Tejera A, Harley CB, Blasco MA. Aging Cell. 2011;10:604-621. doi:10.1111/j.1474-9726.2011.00700.x
- Molgora B, Bateman R, Sweeney G, Finger D, Dimler T, Effros RB, Valenzuela HF. Cells. 2013;2:57-66. doi:10.3390/cells2010057

Written by Anthony Loera, Founder & President. Scientifically reviewed by Dr. Hector Valenzuela, Ph.D., Chief Science Officer. Last updated November 16, 2026.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 RevGenetics · Terms